Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio‐resistance in breast cancer

Published on Feb 1, 2016in Molecular Oncology5.962
· DOI :10.1016/j.molonc.2015.09.009
Nouf Alsubhi4
Estimated H-index: 4
(University of Nottingham),
Fiona K. Middleton6
Estimated H-index: 6
(Newcastle University)
+ 12 AuthorsSrinivasan Madhusudan32
Estimated H-index: 32
(University of Nottingham)
Abstract Radiation-induced DNA damage activates the DNA damage response (DDR). DDR up-regulation may predict radio-resistance and increase the risk of early local recurrence despite radiotherapy in early stage breast cancers. In 1755 early stage breast cancers, DDR signalling [ATM, ATR, total Ckh1, Chk1 phosphorylated at serine 345 (pChk1), Chk2, p53], base excision repair [PARP1, POLβ, XRCC1, FEN1, SMUG1], non-homologous end joining (Ku70/Ku80, DNA-PKcs) and homologous recombination [RAD51, BRCA1, γH2AX, BLM, WRN, RECQL5, PTEN] protein expression was correlated to time to early local recurrence. Pre-clinically, radio-sensitization by inhibition of Chk1 activation by ATR inhibitor (VE-821) and inhibition of Chk1 (V158411) were investigated in MDA-MB-231 (p53 mutant) and MCF-7 (p53 wild-type) breast cancer cells. In the whole cohort, 208/1755 patients (11.9%) developed local recurrence of which 126 (61%) developed local recurrence within 5 years of initiation of primary therapy. Of the 20 markers tested, only pChk1 and p53 significantly associated with early local recurrence (p value = 0.015 and 0.010, respectively). When analysed together, high cytoplasmic pChk1-nuclear pChk1 (p = 0.039), high cytoplasmic pChk1-p53 (p = 0.004) and high nuclear pChk1-p53 (p = 0.029) co-expression remain significantly linked to early local recurrence. In multivariate analysis, cytoplasmic pChk1 level independently predicted early local recurrence (p = 0.025). In patients who received adjuvant local radiotherapy (n = 949), p53 (p = 0.014) and high cytoplasmic pChk1-p53 (p = 0.017) remain associated with early local recurrence. Pre-clinically, radio-sensitisation by VE-821 or V158411 was observed in both MCF-7 and MDA-MB-231 cells and was more pronounced in MCF-7 cells. We conclude that pChk1 is a predictive biomarker of radiotherapy resistance and early local recurrence.
  • References (45)
  • Citations (12)
📖 Papers frequently viewed together
278 Citations
13 Citations
6 Authors (Ryan Wolfort, ..., Benjamin D. Li)
13 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Arvind Arora (University of Nottingham)H-Index: 12
#2Tarek M. A. Abdel-Fatah (University of Nottingham)H-Index: 17
Last. Srinivasan Madhusudan (University of Nottingham)H-Index: 32
view all 13 authors...
Bloom syndrome helicase (BLM) has key roles in homologous recombination repair, telomere maintenance, and DNA replication. Germ-line mutations in the BLM gene causes Bloom syndrome, a rare disorder characterized by premature aging and predisposition to multiple cancers, including breast cancer. The clinicopathologic significance of BLM in sporadic breast cancers is unknown. We investigated BLM mRNA expression in the Molecular Taxonomy of Breast Cancer International Consortium cohort ( n = 1,950)...
12 CitationsSource
#1Hui Tian (Xuzhou Medical College)H-Index: 10
#2Zhen Gao (Xuzhou Medical College)H-Index: 3
Last. Junnian Zheng (Xuzhou Medical College)H-Index: 22
view all 8 authors...
Abstract Genomic stability depends on an efficient DNA damage repair system to keep the chromosomes intact. Unrepaired DNA damage not only causes cell cycle arrest, apoptosis, but also accumulates genome mutations. DNA damage response (DDR) exhibits a critical function on the protection against human cancer, as indicated by the high predisposition to cancer of individuals with germ-line mutations in DDR genes. However, a defective DNA repair is liked intimately with the unchecked proliferation a...
67 CitationsSource
#1Tarek M. A. Abdel-Fatah (University of Nottingham)H-Index: 17
#2Fiona K. Middleton (Newcastle University)H-Index: 6
Last. Srinivasan Madhusudan (University of Nottingham)H-Index: 32
view all 15 authors...
Background: ATR-Chk1 signalling network is critical for genomic stability. ATR-Chk1 may be deregulated in breast cancer and have prognostic, predictive and therapeutic significance. Patients and methods: We investigated ATR and phosphorylated CHK1Ser345 protein (pChk1) expression in 1712 breast cancers (Nottingham Tenovus series). ATR and Chk1 mRNA were evaluated in 1950 breast cancers (METABRIC cohort). Pre-clinically, biological consequences of ATR gene knockdown or ATR inhibition by small mol...
33 CitationsSource
#1Tao Chen (Newcastle University)H-Index: 9
#2Fiona K. Middleton (Newcastle University)H-Index: 6
Last. Nicola J. Curtin (Newcastle University)H-Index: 56
view all 6 authors...
Abstract Background ATR, which signals DNA damage to S/G2 cell cycle checkpoints and for repair, is an attractive target in cancer therapy. ATR inhibitors are being developed and a pharmacodynamic assay is needed to support clinical studies. Methods Phosphorylation of ATR targets, Chk1 and H2AX, was evaluated in MCF7 and K562 cells, human volunteer PBMCs and whole blood by Western blot, immunofluorescence microscopy and flow cytometry after DNA damage. The effect of cell cycle phase, ATR knockdo...
9 CitationsSource
#1Nada Albarakati (University of Nottingham)H-Index: 8
#2Tarek M. A. Abdel-Fatah (University of Nottingham)H-Index: 17
Last. Srinivasan Madhusudan (University of Nottingham)H-Index: 32
view all 17 authors...
BRCA1, a key factor in homologous recombination (HR) repair may also regulate base excision repair (BER). Targeting BRCA1-BER deficient cells by blockade of ATM and DNA-PKcs could be a promising strategy in breast cancer. We investigated BRCA1, XRCC1 and pol β protein expression in two cohorts (n = 1602 sporadic and n = 50 germ-line BRCA1 mutated) and mRNA expression in two cohorts (n = 1952 and n = 249). Artificial neural network analysis for BRCA1-DNA repair interacting genes was conducted in ...
32 CitationsSource
#1Rozenn JosseH-Index: 3
#2Scott E. Martin (NIH: National Institutes of Health)H-Index: 23
Last. Yves PommierH-Index: 103
view all 13 authors...
Camptothecin and its derivatives, topotecan and irinotecan, are specific topoisomerase I (Top1) inhibitors and potent anticancer drugs killing cancer cells by producing replication-associated DNA double-strand breaks, and the indenoisoquinoline LMP-400 (indotecan) is a novel Top1 inhibitor in clinical trial. To develop novel drug combinations, we conducted a synthetic lethal siRNA screen using a library that targets nearly 7,000 human genes. Depletion of ATR, the main transducer of replication s...
68 CitationsSource
#2Rebecca RawlinsonH-Index: 3
Last. Andrew MasseyH-Index: 20
view all 3 authors...
Background Chk1 inhibitors are currently in clinical trials as putative potentiators of cytotoxic chemotherapy drugs. Chk1 inhibitors may exhibit single agent anti-tumor activity in cancers with underlying DNA repair, DNA damage response or DNA replication defects.
51 CitationsSource
#1Tarek M. A. Abdel-Fatah (University of Nottingham)H-Index: 17
#2Arvind Arora (University of Nottingham)H-Index: 12
Last. Srinivasan Madhusudan (University of Nottingham)H-Index: 32
view all 13 authors...
ATM-Chk2 network is critical for genomic stability, and its deregulation may influence breast cancer pathogenesis. We investigated ATM and Chk2 protein levels in two cohorts [cohort 1 (n = 1650) and cohort 2 (n = 252)]. ATM and Chk2 mRNA expression was evaluated in the Molecular Taxonomy of Breast Cancer International Consortium cohort (n = 1950). Low nuclear ATM protein level was significantly associated with aggressive breast cancer including larger tumors, higher tumor grade, higher mitotic i...
16 CitationsSource
Abstract Significance: Ionizing radiation (IR) is an effective and commonly employed treatment in the management of more than half of human malignancies. Because IR's ability to control tumors mainly relies on DNA damage, the cell's DNA damage response and repair (DRR) processes may hold the key to determining tumor responses. IR-induced DNA damage activates a number of DRR signaling cascades that control cell cycle arrest, DNA repair, and the cell's fate. DNA double-strand breaks (DSBs) generat...
72 CitationsSource
#1Barbora Salovska (Charles University in Prague)H-Index: 5
#2Ivo Fabrik (Charles University in Prague)H-Index: 1
Last. Aleš TichýH-Index: 9
view all 7 authors...
DNA damaging agents such as ionizing radiation or chemotherapy are frequently used in oncology. DNA damage response (DDR)—triggered by radiation-induced double strand breaks—is orchestrated mainly by three Phosphatidylinositol 3-kinase-related kinases (PIKKs): Ataxia teleangiectasia mutated (ATM), DNA-dependent protein kinase (DNA-PK) and ATM and Rad3-related kinase (ATR). Their activation promotes cell-cycle arrest and facilitates DNA damage repair, resulting in radioresistance. Recently develo...
13 CitationsSource
Cited By12
#1Hannah Smith (Newcastle University)H-Index: 1
#2Harriet E. D. Southgate (Newcastle University)
Last. Nicola J. Curtin (Newcastle University)H-Index: 56
view all 4 authors...
DNA damage response (DDR) pathway prevents high level endogenous and environmental DNA damage being replicated and passed on to the next generation of cells via an orchestrated and integrated network of cell cycle checkpoint signalling and DNA repair pathways. Depending on the type of damage, and where in the cell cycle it occurs different pathways are involved, with the ATM-CHK2-p53 pathway controlling the G1 checkpoint or ATR-CHK1-Wee1 pathway controlling the S and G2/M checkpoints. Loss of G1...
: Oligonucleotide/oligosaccharide-binding (OB)-fold proteins play essential roles in the regulation of genome and its correct transformation to the subsequent generation. To maintain the genomic stability, OB-fold proteins are implicated in various cellular processes including DNA replication, DNA repair, cell cycle regulation and maintenance of telomere. The diverse functional spectrums of OB-fold proteins are mainly due to their involvement in protein-DNA and protein-protein complexes. Mutatio...
#1Etna Abad (UPF: Pompeu Fabra University)H-Index: 2
#2Dmitry Graifer (NSU: Novosibirsk State University)H-Index: 4
Last. Alex LyakhovichH-Index: 16
view all 3 authors...
Abstract The cancer stem cell (CSC) model defines tumors as hierarchically organized entities, containing a small population of tumorigenic CSC, or tumour-initiating cells, placed at the apex of this hierarchy. These cells may share common qualities with chemo- and radio-resistant cancer cells and contribute to self-renewal activities resulting in tumour formation, maintenance, growth and metastasis. Yet, it remains obscure what self-defense mechanisms are utilized by these cells against the che...
1 CitationsSource
#1Lukas GoreckiH-Index: 5
#2Martin AndrsH-Index: 6
Last. Jan KorabecnyH-Index: 21
view all 4 authors...
Abstract Chemoresistance, radioresistance, and the challenge of achieving complete resection are major driving forces in the search for more robust and targeted anticancer therapies. Targeting the DNA damage response has recently attracted research interest, as these processes are enhanced in tumour cells. The major replication stress responder is ATM and Rad3-related (ATR) kinase, which is attracting attention worldwide with four drug candidates currently in phase I/II clinical trials. This rev...
Abstract The acquisition of genetic alterations, clonal evolution, and the tumor microenvironment promote cancer progression, metastasis and therapy resistance. These events correspond to the establishment of the great phenotypic heterogeneity and plasticity of cancer cells that contribute to tumor progression and resistant disease. Targeting resistant cancers is a major challenge in oncology; however, the underlying processes are not yet fully understood. Even though current treatments can redu...
4 CitationsSource
#1Chenfeng He (Kyoto University)H-Index: 1
#2Kosuke Kawaguchi (Kyoto University)H-Index: 9
Last. Masakazu Toi (Kyoto University)H-Index: 66
view all 3 authors...
Cell DNA is continuously attacked by endogenous and exogenous agents, which causes DNA damage. During long-term evolution, complex defense systems for DNA damage repair are formed by cells to maintain genome stability. Defects in the DNA damage repair process may lead to various diseases, including tumors. Therefore, DNA damage repair systems have become a new anti-tumor drug target. To date, a number of inhibitors related to DNA damage repair systems have been developed, particularly for tumors...
2 CitationsSource
#1Alfredo Cruz-Gregorio (UNAM: National Autonomous University of Mexico)H-Index: 3
#2Imelda Martínez-Ramírez (UNAM: National Autonomous University of Mexico)H-Index: 3
Last. Marcela LizanoH-Index: 20
view all 4 authors...
Head and neck cancer (HNC) is the sixth cause of cancer-related death worldwide. Head and neck squamous cells carcinoma (HNSCC) is the most frequent subtype of HNC. The development of HNSCC is associated to alcohol consumption, smoking or infection by high-risk human Papillomavirus (HR-HPV). Although the incidence of cancers associated with alcohol and tobacco has diminished, HNSCC associated with HR-HPV has significantly increased in recent years. However, HPV-positive HNSCC responds well to tr...
2 CitationsSource
#1Thomas Grellety (French Institute of Health and Medical Research)H-Index: 1
#2Celine Callens (Curie Institute)H-Index: 11
Last. Bruno Cardinaud (French Institute of Health and Medical Research)H-Index: 16
view all 11 authors...
Purpose: Our aim was to identify predictive factors of abiraterone acetate (AA) efficacy and putative new druggable targets in androgen receptor (AR)-positive triple-negative breast cancer (TNBC) treated in the UCBG 2012-1 trial. Experimental Design:We defined AA response as either complete or partial response, or stable disease at 6 months. We sequenced 91 general and breast cancer-associated genes from the tumor DNA samples. We analyzed transcriptomes from the extracted RNA samples on a Nanost...
2 CitationsSource
#1Fiona K. MiddletonH-Index: 6
#2John PollardH-Index: 19
Last. Nicola J. CurtinH-Index: 56
view all 3 authors...
Ataxia telangiectasia mutated and Rad3 related kinase (ATR) signals replication stress and DNA damage to S and G2 arrest and promotes DNA repair. Mutations in p53, critical for G1 checkpoint control, are common in cancer and predicted to confer vulnerability to ATR inhibitors. Reported data on the impact of p53 status are variable possibly because of the use of unmatched cells and surrogate endpoints of survival. The cytotoxicity of VE-821 alone and its ability to potentiate radiation and gemcit...
2 CitationsSource
#1Mu Yao (RPA: Royal Prince Alfred Hospital)H-Index: 11
#2Linda Rogers (USYD: University of Sydney)H-Index: 5
Last. Qihan Dong (USYD: University of Sydney)H-Index: 20
view all 10 authors...
Abstract Radiation therapy is used to treat cancer by radiation-induced DNA damage. Despite the best efforts to eliminate cancer, some cancer cells survive irradiation, resulting in cancer progression or recurrence. Alteration in DNA damage repair pathways is common in cancers, resulting in modulation of their response to radiation. This article focuses on the recent findings about molecules and pathways that potentially can be targeted to sensitize prostate cancer cells to ionizing radiation, t...
2 CitationsSource